FDA NDC Directory · JSON-LD · Markdown
NDC 0032-0045 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE
| Generic name | Pancrelipase |
|---|---|
| Labeler / Manufacturer | AbbVie Inc. |
| Marketing category | Biologic License Application · App BLA020725 |
| Dosage form / route | CAPSULE, DELAYED RELEASE · ORAL |
| Active ingredients | PANCRELIPASE AMYLASE (15000 [USP'U]/1) PANCRELIPASE LIPASE (3000 [USP'U]/1) PANCRELIPASE PROTEASE (9500 [USP'U]/1) |
| Marketing started | 20231012 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).